|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of DICE Therapeutics (NASDAQ: DICE) through any online brokerage.
The latest price target for DICE Therapeutics (NASDAQ: DICE) was reported by B of A Securities on October 11, 2021. The analyst firm set a price target for 41.00 expecting DICE to rise to within 12 months (a possible 40.99% upside). 1 analyst firms have reported ratings in the last year.
The stock price for DICE Therapeutics (NASDAQ: DICE) is $29.08 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for DICE Therapeutics.
DICE Therapeutics’s $Q4 earnings are confirmed for after-market on February 25, 2022.
There is no upcoming split for DICE Therapeutics.
DICE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.